← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Paradigm Pharmaceuticals, Llc
Roseville, MN
$3,681,593
Total funding
19
Grants
Funding over time
peak $956.7K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$3,681,593 · 19
By mechanism
R44$2,081,592 · 3
R43$1,600,001 · 16
Investigators at Paradigm Pharmaceuticals, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
Phase II SBIR: WHI-07: A Novel Dual-Function Microbicide$378,654
R44 · FY2005 · HD
LFM-A13: An antileukemic/antithrombotic agent$378,050
R44 · FY2005 · HL
LFM-A13: An antileukemic/antithrombotic agent$371,950
R44 · FY2004 · HL
Phase II SBIR: WHI-07: A Novel Dual-Function Microbicide$371,348
R44 · FY2004 · HD
VANADOCENES AS A NEW CLASS OF SPERMICIDAL DRUGS$293,876
R44 · FY2006 · HD
VANADOCENES AS A NEW CLASS OF SPERMICIDAL DRUGS$287,714
R44 · FY2007 · HD
PHI-443: Novel Non-Spermicidal Anti-HIV Microbicide$100,001
R43 · FY2003 · HD
COBRA-1: A Novel Tubulin Depolymerizing Anticancer Agent$100,000
R43 · FY2003 · CA
Vanadocenes as a New Class of Spermicidal Drugs$100,000
R43 · FY2003 · HD
LFM-A13 for Prevention of Fatal Thromboembolism$100,000
R43 · FY2002 · HL
Rationally Designed NNRTI Agents$100,000
R43 · FY2002 · AI
PHI-381: A Novel Anti-Leukemic Agent$100,000
R43 · FY2003 · CA
FLP-102: Rationally Engineered Antiviral Protein$100,000
R43 · FY2003 · GM
PHI 346: A Novel Dual-Function Microbicide$100,000
R43 · FY2003 · AI
Treatment of Asthma by Targeting JAK3 with JANEX-1$100,000
R43 · FY2003 · HL
Stampidine: A Novel Broad-Spectrum Antiviral Agent$100,000
R43 · FY2003 · AI
Targeting JAK-3 with WHI-P97 for Treatment of Asthma$100,000
R43 · FY2003 · HL
Stampidine: A Novel Broad-Spectrum Anti-HIV Microbicide$100,000
R43 · FY2005 · AI
Formulation of dosage of the anti-HIV agent, DDE113$100,000
R43 · FY2005 · AI
WHI-07: A Novel Dual-Function Microbicide$100,000
R43 · FY2002 · HD